Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein C is a vitamin K-dependent plasma glycoprotein that functions as a major anticoagulant in the blood. It is synthesized in the liver as an inactive zymogen and is activated by the thrombin-thrombomodulin complex on endothelial cells. Activated Protein C (APC) degrades coagulation factors Va and VIIIa, thereby inhibiting further thrombin generation and clot formation. Beyond anticoagulation, APC has anti-inflammatory effects and helps maintain vascular barrier function. Deficiency or dysfunction of Protein C leads to increased risk for abnormal blood clotting disorders.
Upon activation by the thrombin-thrombomodulin complex, Protein C becomes activated protein C (APC), which acts as a serine protease anticoagulant by degrading coagulation factors Va and VIIIa, thereby inhibiting further thrombin generation and clot formation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein C (PC).